Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM: An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988, 2: 90-95. 10.1016/0888-7543(88)90113-9.
Article
CAS
PubMed
Google Scholar
Aartsma-Rus A, van Deutekom JC, Fokkema IF, van Ommen GJ, den Dunnen JT: Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve. 2006, 34: 135-144. 10.1002/mus.20586.
Article
CAS
PubMed
Google Scholar
Manzur AY, Muntoni F: Diagnosis and new treatments in muscular dystrophies. J Neurol Neurosurg Psychiatry. 2009, 80: 706-714.
Article
CAS
PubMed
Google Scholar
Trollet C, Athanasopoulos T, Popplewell L, Malerba A, Dickson G: Gene therapy for muscular dystrophy: current progress and future prospects. Expert Opinion on Biological Therapy. 2009, 9: 849-866. 10.1517/14712590903029164.
Article
CAS
PubMed
Google Scholar
van Ommen GJ, van Deutekom JC, Aartsma-Rus A: The therapeutic potential of antisense-mediated exon skipping. Curr Opin Mol Ther. 2008, 10: 140-149.
CAS
PubMed
Google Scholar
Aartsma-Rus A, Bremmer-Bout M, Janson AA, den Dunnen JT, van Ommen GJ, van Deutekom JC: Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy. Neuromuscul Disord. 2002, 12 (Suppl 1): S71-S77.
Article
PubMed
Google Scholar
Aartsma-Rus A, Janson AA, Kaman WE, Bremmer-Bout M, den Dunnen JT, Baas F, van Ommen GJ, van Deutekom JC: Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients. Hum Mol Genet. 2003, 12: 907-914. 10.1093/hmg/ddg100.
Article
CAS
PubMed
Google Scholar
Aartsma-Rus A, Janson AA, Kaman WE, Bremmer-Bout M, van Ommen GJ, den Dunnen JT, van Deutekom JC: Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense. Am J Hum Genet. 2004, 74: 83-92. 10.1086/381039.
Article
CAS
PubMed
Google Scholar
Mann CJ, Honeyman K, McClorey G, Fletcher S, Wilton SD: Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy. J Gene Med. 2002, 4: 644-654. 10.1002/jgm.295.
Article
CAS
PubMed
Google Scholar
Bremmer-Bout M, Aartsma-Rus A, de Meijer EJ, Kaman WE, Janson AA, Vossen RH, van Ommen GJ, den Dunnen JT, van Deutekom JC: Targeted exon skipping in transgenic hDMD mice: A model for direct preclinical screening of human-specific antisense oligonucleotides. Mol Ther. 2004, 10: 232-240. 10.1016/j.ymthe.2004.05.031.
Article
CAS
PubMed
Google Scholar
Heemskerk HA, de Winter CL, de Kimpe SJ, van Kuik-Romeijn P, Heuvelmans N, Platenburg GJ, van Ommen GJ, van Deutekom JC, Aartsma-Rus A: In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping. J Gene Med. 2009, 11: 257-266. 10.1002/jgm.1288.
Article
CAS
PubMed
Google Scholar
van Deutekom JC, Janson AA, Ginjaar IB, Frankhuizen WS, Aartsma-Rus A, Bremmer-Bout M, den Dunnen JT, Koop K, van der Kooi AJ, Goemans NM, de Kimpe SJ, Ekhart PF, Venneker EH, Platenburg GJ, Verschuuren JJ, van Ommen GJ: Local Dystrophin Restoration with Antisense Oligonucleotide PRO051. N Engl J Med. 2007, 357: 2677-2686. 10.1056/NEJMoa073108.
Article
CAS
PubMed
Google Scholar
Kinali M, rechavala-Gomeza V, Feng L, Cirak S, Hunt D, Adkin C, Guglieri M, Ashton E, Abbs S, Nihoyannopoulos P, Garralda ME, Rutherford M, McCulley C, Popplewell L, Graham IR, Dickson G, Wood MJ, Wells DJ, Wilton SD, Kole R, Straub V, Bushby K, Sewry C, Morgan JE, Muntoni F: Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol. 2009, 8: 918-928. 10.1016/S1474-4422(09)70211-X.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yoshida N, Yoshida S, Koishi K, Masuda K, Nabeshima Y: Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'. J Cell Sci. 1998, 111: 769-779.
CAS
PubMed
Google Scholar
Hawke TJ, Garry DJ: Myogenic satellite cells: physiology to molecular biology. J Appl Physiol. 2001, 91: 534-551.
CAS
PubMed
Google Scholar
Blau HM, Webster C, Pavlath GK, Chiu CP: Evidence for defective myoblasts in Duchenne muscular dystrophy. Adv Exp Med Biol. 1985, 182: 85-110.
Article
CAS
PubMed
Google Scholar
Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibe B, Bouix J, Caiment F, Elsen JM, Eychenne F, Larzul C, Laville E, Meish F, Milenkovic D, Tobin J, Charlier C, Georges M: A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet. 2006, 38: 813-818. 10.1038/ng1810.
Article
CAS
PubMed
Google Scholar
McPherron AC, Lawler AM, Lee SJ: Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997, 387: 83-90. 10.1038/387083a0.
Article
CAS
PubMed
Google Scholar
McPherron AC, Lee SJ: Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA. 1997, 94: 12457-12461. 10.1073/pnas.94.23.12457.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ: Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med. 2004, 350: 2682-2688. 10.1056/NEJMoa040933.
Article
CAS
PubMed
Google Scholar
Shelton GD, Engvall E: Gross muscle hypertrophy in whippet dogs is caused by a mutation in the myostatin gene. Neuromuscul Disord. 2007, 17: 721-722. 10.1016/j.nmd.2007.06.008.
Article
PubMed
Google Scholar
Rebbapragada A, Benchabane H, Wrana JL, Celeste AJ, Attisano L: Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol. 2003, 23: 7230-7242. 10.1128/MCB.23.20.7230-7242.2003.
Article
CAS
PubMed
PubMed Central
Google Scholar
Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R: Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem. 2002, 277: 49831-49840. 10.1074/jbc.M204291200.
Article
CAS
PubMed
Google Scholar
McFarlane C, Hennebry A, Thomas M, Plummer E, Ling N, Sharma M, Kambadur R: Myostatin signals through Pax7 to regulate satellite cell self-renewal. Experimental Cell Research. 2008, 314: 317-329. 10.1016/j.yexcr.2007.09.012.
Article
CAS
PubMed
Google Scholar
Rios R, Carneiro I, Arce VM, Devesa J: Myostatin Regulates Cell Survival during C2C12 Myogenesis. Biochemical and Biophysical Research Communications. 2001, 280: 561-566. 10.1006/bbrc.2000.4159.
Article
CAS
PubMed
Google Scholar
Taylor WE, Bhasin S, Artaza J, Byhower F, Azam M, Willard DH, Kull FC, Gonzalez-Cadavid N: Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab. 2001, 280: E221-E228.
CAS
PubMed
Google Scholar
Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, Kambadur R: Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem. 2000, 275: 40235-40243. 10.1074/jbc.M004356200.
Article
CAS
PubMed
Google Scholar
Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, Khurana TS: Functional improvement of dystrophic muscle by myostatin blockade. Nature. 2002, 420: 418-421. 10.1038/nature01154.
Article
CAS
PubMed
Google Scholar
Krivickas LS, Walsh R, Amato AA: Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO-029. Muscle Nerve. 2009, 39: 3-9. 10.1002/mus.21200.
Article
CAS
PubMed
Google Scholar
Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, Flanigan KM, Pestronk A, Tawil R, Wolfe GI, Eagle M, Florence JM, King WM, Pandya S, Straub V, Juneau P, Meyers K, Csimma C, Araujo T, Allen R, Parsons SA, Wozney JM, Lavallie ER, Mendell JR: A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol. 2008, 63: 561-571. 10.1002/ana.21338.
Article
CAS
PubMed
Google Scholar
Bogdanovich S, Perkins KJ, Krag TO, Whittemore LA, Khurana TS: Myostatin propeptide-mediated amelioration of dystrophic pathophysiology. FASEB J. 2005, 19: 543-549. 10.1096/fj.04-2796com.
Article
CAS
PubMed
Google Scholar
Matsakas A, Foster K, Otto A, Macharia R, Elashry MI, Feist S, Graham I, Foster H, Yaworsky P, Walsh F, Dickson G, Patel K: Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice. Neuromuscul Disord. 2009, 19: 489-499. 10.1016/j.nmd.2009.06.367.
Article
PubMed
Google Scholar
Qiao C, Li J, Jiang J, Zhu X, Wang B, Li J, Xiao X: Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice. Hum Gene Ther. 2008, 19: 241-254. 10.1089/hum.2007.159.
Article
CAS
PubMed
Google Scholar
Zhao B, Li EJ, Wall RJ, Yang J: Coordinated patterns of gene expression for adult muscle build-up in transgenic mice expressing myostatin propeptide. BMC Genomics. 2009, 10: 305-10.1186/1471-2164-10-305.
Article
PubMed
PubMed Central
Google Scholar
Lee SJ, Reed LA, Davies MV, Girgenrath S, Goad ME, Tomkinson KN, Wright JF, Barker C, Ehrmantraut G, Holmstrom J, Trowell B, Gertz B, Jiang MS, Sebald SM, Matzuk M, Li E, Liang LF, Quattlebaum E, Stotish RL, Wolfman NM: Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci USA. 2005, 102: 18117-18122. 10.1073/pnas.0505996102.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li ZB, Kollias HD, Wagner KR: Myostatin directly regulates skeletal muscle fibrosis. J Biol Chem. 2008, 283: 19371-19378. 10.1074/jbc.M802585200.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dumonceaux J, Marie S, Beley C, Trollet C, Vignaud A, Ferry A, Butler-Browne G, Garcia L: Combination of Myostatin Pathway Interference and Dystrophin Rescue Enhances Tetanic and Specific Force in Dystrophic mdx Mice. Mol Ther. 2010
Google Scholar
Tang Y, Cummins J, Huard J, Wang B: AAV-directed muscular dystrophy gene therapy. Expert Opin Biol Ther. 2010, 10: 395-408. 10.1517/14712591003604690.
Article
CAS
PubMed
Google Scholar
Le RF, Charton K, Lorson CL, Richard I: RNA-targeting approaches for neuromuscular diseases. Trends Mol Med. 2009, 15: 580-591. 10.1016/j.molmed.2009.10.005.
Article
Google Scholar
Liu CM, Yang Z, Liu CW, Wang R, Tien P, Dale R, Sun LQ: Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice. Gene Ther. 2008, 15: 155-160. 10.1038/sj.gt.3303016.
Article
PubMed
Google Scholar
Magee TR, Artaza JN, Ferrini MG, Vernet D, Zuniga FI, Cantini L, Reisz-Porszasz S, Rajfer J, Gonzalez-Cadavid NF: Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass. J Gene Med. 2006, 8: 1171-1181. 10.1002/jgm.946.
Article
CAS
PubMed
Google Scholar
Aartsma-Rus A, Janson AA, Kaman WE, Bremmer-Bout M, den Dunnen JT, Baas F, van Ommen GJ, van Deutekom JC: Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients. Hum Mol Genet. 2003, 12: 907-914. 10.1093/hmg/ddg100.
Article
CAS
PubMed
Google Scholar
Zhu CH, Mouly V, Cooper RN, Mamchaoui K, Bigot A, Shay JW, Di Santo JP, Butler-Browne GS, Wright WE: Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. aging cell. 2007, 6: 515-523. 10.1111/j.1474-9726.2007.00306.x.
Article
CAS
PubMed
Google Scholar
Aartsma-Rus A, van Vliet L, Hirschi M, Janson AA, Heemskerk H, de Winter CL, de Kimpe S, van Deutekom JC, 't Hoen PA, van Ommen GJ: Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms. Mol Ther. 2009, 17: 548-553. 10.1038/mt.2008.205.
Article
CAS
PubMed
Google Scholar
Amthor H, Otto A, Macharia R, McKinnell I, Patel K: Myostatin imposes reversible quiescence on embryonic muscle precursors. Dev Dyn. 2006, 235: 672-680. 10.1002/dvdy.20680.
Article
CAS
PubMed
Google Scholar
McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R: Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol. 2003, 162: 1135-1147. 10.1083/jcb.200207056.
Article
CAS
PubMed
PubMed Central
Google Scholar
Aartsma-Rus A, de Winter CL, Janson AA, Kaman WE, van Ommen GJ, den Dunnen JT, van Deutekom JC: Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: indication for steric hindrance of SR protein binding sites. Oligonucleotides. 2005, 15: 284-297. 10.1089/oli.2005.15.284.
Article
CAS
PubMed
Google Scholar
Mathews DH, Turner DH, Zuker M: RNA secondary structure prediction. Curr Protoc Nucleic Acid Chem. 2007, Chapter 11 (Unit 11.2).
Kang JK, Malerba A, Popplewell L, Foster K, Dickson G: Antisense-induced Myostatin Exon Skipping Leads to Muscle Hypertrophy in Mice Following Octa guanidine Morpholino Oligomer Treatment. Mol Ther. 2010
Google Scholar
Lee SJ: Quadrupling Muscle Mass in Mice by Targeting TGF-β Signaling Pathways. PLoS ONE. 2007, 2: e789-10.1371/journal.pone.0000789.
Article
PubMed
PubMed Central
Google Scholar
Souza TA, Chen X, Guo Y, Sava P, Zhang J, Hill JJ, Yaworsky PJ, Qiu Y: Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators. Mol Endocrinol. 2008, 22: 2689-2702. 10.1210/me.2008-0290.
Article
CAS
PubMed
Google Scholar